Prospective clinical study of the therapeutic effects of prostaglandin in patients with combined lumbar spinal stenosis and arteriosclerosis obliterans showing intermittent claudicatio
Not Applicable
- Conditions
- Patients with combined lumbar spinal stenosis and arteriosclerosis obliterans
- Registration Number
- JPRN-UMIN000005959
- Lead Sponsor
- Tokai University Hospital Department of Orthopaedic Surgery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
The patients who meet any of the following exclusion criteria are excluded. 1) Patients who have ethical difficulties due to special consideration required for them or their family. 2) Patients with diabetes, chronic renal failure, etc. who are suspected to have a complication of peripheral nerve disorder or circulatory disorder. 3) Patients who are receiving administration of anticoagulant, etc. 4) Patients who have a history of surgical treatment for the spine/spinal cord. 5) Patients who have problematic infection. 6) Patients who do not understand the objectives of this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method